# US 2026/0077193 A1 · Non-invasive peripheral nerve stimulation system and method for treating anxiety and insomnia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077193 A1
- Document ID: US20260077193A1
- Status: Published application
- Kind: A1
- Application number: 19/012,481
- Filed: 2025-01-07
- Published: 2026-03-19
- Earliest claimed: 2024-09-13
- Assignees: Roga Life Canada, Inc.
- Applicants: Roga Life Canada, Inc.
- Inventors: Ami Lebendiker; Alison Smith; Brian Cooper
- Web page: https://patentgrep.com/patent/US20260077193A1

## CPC

- A61N 1/36025: {for treating a mental or cerebral condition}
- A61N 1/025: {Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors}
- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/0496: {characterised by using specific chemical compositions, e.g. hydrogel compositions, adhesives}
- A61N 1/36034: {specified by the stimulation parameters}
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/70: relating to mental therapies, e.g. psychological therapy or autogenous training
- G16H 40/63: for local operation
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A Peripheral Nerve Stimulation (PNS) system and method are disclosed. The system includes a headset with ear hooks and electrodes for placement on the mastoid processes. A stimulation device connected to the headset via lead wires delivers a pulsed electrical current to the electrodes. The device communicates with a computing device equipped with a mobile application that controls the stimulation characteristics. The mobile application allows users to adjust settings, monitor progress, and access treatment sessions. The system also includes snap ports for electrode attachment, self-adhesive hydrogel electrodes, and current control mechanisms using a digital potentiometer and waveform generator. The method includes pre- and post-session anxiety rating, personalized treatment based on user inputs, and tracking of physiological biomarkers. The application supports multiple operating systems, secure cloud data storage, and enables data sharing with healthcare providers. The invention provides a comprehensive, customizable, safe solution for managing anxiety and insomnia.

## Claims

### Claim 1

A non-invasive Peripheral Nerve Stimulation (PNS) system for treatment of anxiety and insomnia, said system comprising:
a headset including two ear hooks configured to ergonomically fit around ears of a user;
an adhesive electrode connected to each of the two ear hooks for placement on skin of mastoid processes of the user;
a stimulation device connected to the headset and configured to deliver a pulsed electrical current to each of the electrodes via a lead wire;
wherein the stimulation device is in communication with a computing device having a mobile application installed on the computing device, said mobile application is configured to control a plurality of output stimulation characteristics of the stimulation device, wherein the mobile application allows the user to adjust the output stimulation characteristics, monitor treatment progress, and access a plurality of interactive treatment sessions.

### Claim 2 (depends on 1)

The PNS system of claim 1, wherein each of the ear hooks includes a snap port for attachment of the adhesive electrodes to the skin.

### Claim 3 (depends on 1)

The PNS system of claim 1, wherein the electrodes are self-adhesive, conductive hydrogel disposable electrodes.

### Claim 4 (depends on 1)

The PNS system of claim 1, wherein the output stimulation characteristics of the stimulation device include at least one of: intensity level of the pulsed electrical current, stimulation frequency, treatment duration, and operation mode.

### Claim 5 (depends on 1)

The PNS system of claim 1, wherein the pulsed electrical current is delivered in a low-level pulsed electrical square wave form.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The PNS system of claim 1, wherein the mobile application is configured to measure a plurality of physiological biomarkers associated with anxiety intensity, wherein the physiological biomarkers are selected from heart rate variability, heart rate, skin impedance, skin conductance, blood oxygenation, and skin temperature, to provide personalized treatment recommendations.

### Claim 8 (depends on 1)

The PNS system of claim 1, wherein the mobile application is configured to allow users to create a profile, respond to a validated psychological questionnaire, rate anxiety intensity before and after the interactive treatment sessions, track anxiety over time, and share data with healthcare providers.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The PNS system of claim 1, wherein the mobile application is configured to provide the plurality of interactive treatment sessions generated based on user inputs selected from music, narrator, language, session duration, and topic.

### Claim 11 (depends on 1)

The PNS system of claim 1, wherein the stimulation device further comprises:
a microprocessor;
a digital potentiometer in communication with the microprocessor, the digital potentiometer configured to limit current surges, wherein the digital potentiometer includes a series of physical resistors to regulate current flow to a level not exceeding 2 mA;
a waveform generator connected to digital potentiometer and configured to generate the pulsed electrical current, wherein the microprocessor is configured to:
communicate with the digital potentiometer to read and adjust settings of the digital potentiometer;
communicate with an analog-to-digital converter (ADC) to read values of the ADC and check connectivity status of the electrode based on the ADC readings;
control the interactive treatment sessions based on user inputs; and
operate in different modes including a therapy mode and an idle mode based on the user adjusted output stimulation characteristics;
an integrated timer configured to shut-off the stimulation device after a predetermined time of continuous operation of the stimulation device.

### Claim 12 (depends on 1)

The PNS system of claim 1, wherein the mobile application is available on multiple operating systems and requires users to create a password-protected account for secure access.

### Claim 13

A method for treatment of anxiety and insomnia through a mobile application in communication with a concealable non-invasive peripheral nerve stimulation device, said method comprising:
presenting a user interface on the mobile application for selecting between two modes of a plurality of interactive treatment sessions including a pre-recorded content mode and a dynamically generated meditation mode;
in response to receiving a selection of the pre-recorded content mode:
prompting a user to input a pre-session anxiety rating;
initiating playback of the pre-recorded content;
terminating playback of the pre-recorded content;
prompting the user to input a post-session anxiety rating;
in response to receiving a selection of the dynamically generated meditation mode:
receiving verbal or written input parameters from the user;
configuring the dynamically generated meditation mode based on the input parameters, including selecting a voice, duration, and music;
prompting the user to input a pre-session anxiety rating;
initiating the dynamically generated meditation mode;
terminating the dynamically generated meditation mode;
prompting the user to input a post-session anxiety rating.

### Claim 14 (depends on 13)

The method of claim 13, wherein the method further comprises recording treatment progress of the user on the user interface.

### Claim 15 (depends on 13)

The method of claim 13, wherein the anxiety rating is based on Generalized Anxiety Disorder (GAD) parameters, wherein the GAD parameters includes at least one of nervousness, control, excessive worry, tension, restlessness, irritability and fear.

### Claim 16 (depends on 13)

The method of claim 13, wherein the method further comprises, through the mobile application, creating a user profile by the user, responding to a validated psychological questionnaire, rating anxiety intensity before and after the interactive treatment sessions, tracking anxiety over time, and sharing data with healthcare providers.

### Claim 17

(canceled)

### Claim 18

A Peripheral Nerve Stimulation (PNS) apparatus for treatment of anxiety and insomnia, comprising:
a headset including two ear hooks configured to ergonomically fit around ears of a user;
an adhesive electrode connected to each of the two ear hooks for placement on skin of mastoid processes of the user; and
a stimulation device connected to the headset and configured to generate a plurality of output stimulation characteristics to deliver a pulsed electrical current to each of the electrodes via a lead wire, wherein the output stimulation characteristics are controllable by the user for the treatment of anxiety and insomnia.

### Claim 19 (depends on 18)

The PNS apparatus of claim 18, wherein each of the ear hooks include snap ports for attachment of the adhesive electrodes to the skin.

### Claim 20 (depends on 18)

The PNS apparatus of claim 18, wherein the electrodes are self-adhesive, conductive hydrogel disposable electrodes.

### Claim 21 (depends on 18)

The PNS apparatus of claim 18, wherein the output stimulation characteristics of the stimulation device includes intensity level of the pulsed electrical current, stimulation frequency, treatment duration, and operation mode.

### Claim 22 (depends on 18)

The PNS apparatus of claim 18, wherein the pulsed electrical current is delivered in a low-level pulsed electrical square wave form.

### Claim 23

(canceled)

### Claim 24 (depends on 18)

The PNS apparatus of claim 18, wherein the stimulation device further comprises:
a microprocessor;
a digital potentiometer in communication with the microprocessor, the digital potentiometer configured to limit current surges, wherein the digital potentiometer includes a series of physical resistors to regulate current flow to a level not exceeding 2 mA;
a waveform generator connected to digital potentiometer and configured to generate the pulsed electrical current, wherein the microprocessor is configured to:
communicate with the digital potentiometer to read and adjust settings of the digital potentiometer;
communicate with an analog-to-digital converter (ADC) to read values of the ADC and check connectivity status of the electrode based on the ADC readings; and
operate in different modes including a therapy mode and an idle mode based on the user controlled output stimulation characteristics;
an integrated timer configured to shut-off the stimulation device after a predetermined time of continuous operation of the stimulation device.
